Connect with us

SCIENCE

Rush to trash hydroxychloroquine based on faulty Surgisphere data exposes fundamental flaws in profit-based medical ‘science’

Published

on

As the WHO and prestigious medical journal the Lancet back away from questionable data provided by healthcare analytics firm Surgisphere, ulterior motives for the rush to demonize hydroxychloroquine become clear.

The World Health Organization (WHO) sheepishly resumed testing the off-patent malaria drug hydroxychloroquine on coronavirus patients on Wednesday after pausing that arm of its ‘Solidarity’ clinical trial based on data that appeared to show the drug contributed to higher death rates among test subjects. That data, it turned out, came from a tiny US healthcare analytics firm called Surgisphere, and calling it faulty would be excessively charitable.

Not only is Surgisphere a company lacking in medical expertise – its employees included an “adult” entertainer and a science-fiction writer – but its CEO Sapan Desai co-authored two of the damning studies that used the firm’s data to smear hydroxychloroquine, already thoroughly demonized in the media thanks to its promotion by US President Donald Trump, as a killer. All data is sourced to a proprietary database supposedly containing a veritable ocean of real-time, detailed patient information yet curiously absent from existing medical literature.

The Surgisphere-tainted study appeared to show increased risk of in-hospital deaths and heart problems with no disease-fighting benefits, confirming the suspicions of medical-industry naysayers already inclined to hate the off-patent drug due to the lack of profit potential and Trump’s incessant boosterism. Italy, France, and Germany rushed to ban hydroxychloroquine, citing “an increased risk for adverse reactions with little or no benefit.”

But such a shameless character assassination performed against a potentially-lifesaving drug – especially one with a decades-long track record of safety in malaria, lupus, and arthritis patients that came highly recommended by some of the world’s most eminent disease experts, including France’s Didier Raoult – could only be accomplished with help from industry prejudice. It required ignoring numerous existing studies showing hydroxychloroquine was beneficial in treating early-stage Covid-19 patients, as well as anecdotal reports from thousands of doctors who’d successfully used it.

It also required trusting a fly-by-night company with next to no internet or media presence to make decisions that could affect the lives of millions of people. It’s not like there weren’t warning signs Surgisphere was something other than the top-notch medical analytics firm it presented itself as. The company began life as a textbook publisher in 2008 and hired most of its 11 employees two month ago, according to an investigation by the Guardian, yet it claimed ownership of a massive international database of 96,000 patients in 1,200 hospitals worldwide. One expert interviewed by the outlet said it would be difficult for even a national statistics agency to do in years what Surgisphere had supposedly done in weeks, calling the database “almost certainly a scam.” Yet no one at the Lancet or WHO thought to look a gift horse in the mouth – not when that gift drove a stake through the heart of hydroxychloroquine as Covid-19 treatment.

And while Australian researchers found flaws in the Surgisphere data just days after the May 22 publication of the Lancet study, noting that the number of Covid-19 deaths cited by the study as coming from five hospitals exceeded the entirety of Covid-19 deaths recorded in Australia at that time, the Lancet – instead of investigating just who this Surgisphere company really was, and why it had made such a glaring mistake – merely published a minor retraction related to the Australian data and put the controversy to bed.

The full-frontal assault on hydroxychloroquine was instead allowed to continue unchecked in the media, as mainstream outlets focused their energies on fluffing up remdesivir – a costly, untested drug manufactured by drug maker Gilead that has so far produced lackluster results in clinical trials – and stumping for an eventual vaccine. Hydroxychloroquine’s off-patent status meant it was a dead end as far as profits were concerned, while remdesivir and whatever vaccine is ultimately green-lighted will make a lot of people very rich. Perhaps hoping to throw their audiences off the real reason for their hydroxychloroquine hatred, several outlets hinted that Trump stood to make money off the drug (which costs about 60 cents per pill) – but even Snopes, no fan of the ‘Bad Orange Man’, had to pour cold water on that speculation.

The Lancet and New England Journal of Medicine have – belatedly – published “expressions of concern” about the Surgisphere hydroxychloroquine study, and an independent audit is being conducted. But the problem of biased health authorities selectively embracing some trial results while rejecting others is unlikely to stop there.

The Lancet study is hardly the only one to show hydroxychloroquine lacks efficacy in treating Covid-19. Multiple studies conducted by the US National Institutes of Health on hospitalized (i.e. severely-ill) coronavirus patients have yielded poor results, but even the drug’s most ardent evangelists acknowledge it doesn’t help end-stage or very sick patients. Raoult has even claimed France banned the drug’s use in all but the most severely ill patients in order to discredit it as a treatment. The US National Institutes of Health was publishing studies in its journal Virology touting chloroquine as “a potent inhibitor of SARS coronavirus infection” as far back as 2005, yet ‘coronavirus czar’ Anthony Fauci throws shade at the drug whenever he gets a chance.

As long as deadly diseases like Covid-19 are seen as profit sources first and human rights issues second (or third, or tenth…), treatments that aren’t profitable will always be marginalized in favor of costly and frequently less-effective pharmaceuticals. Drug industry profiteering has already killed hundreds of thousands – if not millions – of people in the US alone. Taking the profit motive out of healthcare can help ensure its body count stays as low as possible.

Think your friends would be interested? Share this story!

SCIENCE

Ohio chemical disaster may hold long-term health risks – experts

Published

on

East Palestine residents remain “in constant contact” with toxic pollutants, a US scientist says

The pollutants in the air of East Palestine, Ohio, may pose long-term health risks, scientists from Texas A&M and Carnegie Mellon University claimed on Wednesday. Their assessment contrasts the US Environmental Protection Agency’s (EPA) assurance that the pollution does not pose an immediate health risk.

Dr. Albert Presto, an associate research professor at Carnegie Mellon University, told CNN on Wednesday that the situation in East Palestine was not an “immediate health concern” but that it could still pose long-term risks as the researchers had no way of telling how long the hazardous chemical concentration would persist. He added that the residents of the city were in “constant contact” with the pollutants and there was no clear understanding of what that level of exposure would mean for the population’s health.

The air in the Ohio city was contaminated in early February, after 38 cars of a Norfolk Southern freight train derailed and spilled out the hazardous materials they were carrying. The accident caused a fire that went on for multiple days and intensified the airborne spread of the chemical pollution, causing a mandatory evacuation of the nearby residents. The EPA has been conducting various tests and measurements in the affected area, claiming there was no immediate risk to the local population.

Another train derails after Ohio chemical spill

Texas A&M and Carnegie Mellon presented their independent assessment in a Twitter post last week. The scientists claim to have used data compiled by the EPA and found that nine of the 50 chemicals found in East Palestine’s air were above the norm for the region. In particular, the report singles out acrolein, a toxic substance used to control plants, algae, rodents and microorganisms.

The EPA responded to the claims in the report from the two universities by dismissing the perceived risks. A spokesperson for the agency told CNN on Monday that the report assumed “a lifetime of exposure, which is constant exposure over approximately 70 years” for the harmful effects to manifest. They added: “EPA does not anticipate levels of these chemicals will stay high for anywhere near that.”

Dr. Ivan Rusyn, the director of the Texas A&M University Superfund Research Center and part of the team that did the analysis, told CNN on Wednesday that “all sides were right” as both parties simply needed to keep monitoring the situation and “do a better job communicating the results.”

PLEASANT MUSIC FOR YOUR CAFE, BAR, RESTAURANT, SWEET SHOP, HOME

SUITABLE MUSIC FOR YOGA LOVERS

Continue Reading

SCIENCE

Seismologist behind Türkiye quake prediction issues another warning

Published

on

Dutch seismologist Frank Hoogerbeets, who rose to international prominence after predicting the devastating earthquakes in Türkiye and Syria last month, has said that the world could be hit with another major quake in the coming days.

Hoogerbeets, who makes his forecasts based on the motions of celestial bodies, published a video on YouTube on Monday in which he warned that “the first week of March is going to be extremely critical.”

“A convergence of critical planetary geometry around March 2 and 5 may result in large to very large seismic activity, possibly even a mega-thrust earthquake around March 3 and 4 and/or March 6 and 7,” the description to the clip read.

In the video itself, the seismologist claimed that the power of the supposed impending quake “may be well over 8 magnitude.”

The affected area could stretch thousands of kilometers, from the Kamchatka Peninsula and the Kuril Islands in Russia’s Far East, all the way down to the Philippines and Indonesia, Hoogerbeets said.

Costs from Türkiye’s massive quake rising

“I’m not exaggerating. I’m not trying to create fear. This is a warning,” insisted the scientist, who works at the Solar System Geometry Survey (SSGEOS).

The head of the Kamchatka branch of the Geophysical Survey of Russia’s Academy of Sciences, Danila Chebrov, has questioned Hoogerbeets’ predictions and described him as an “amateur.” The connection between the movements of the planets in the solar system and seismic activity on Earth “is rather weak, and it’s problematic to use it as the main prognostic tool,” Chebrov explained.

On February 3, Hoogerbeets issued a tweet that read: “Sooner or later there will be a magnitude 7.5 earthquake in this region (South-Central Turkey, Jordan, Syria, Lebanon).”

Three days later, a 7.8 magnitude quake struck Türkiye and Syria. The disaster has caused the deaths of more than 50,000 people, with powerful aftershocks continuing in the region to this day.

Dutch seismologist Hoogerbeets has made predictions down the years which didn’t come true. Commenting on his work earlier this month, Susan Hough of the US Geological Survey insisted that no scientist has “ever predicted a major earthquake.” Hough told NPR that the spot-on forecast for the quakes in Türkiye and Syria was just a coincidence. “It’s the stopped clock that’s right twice a day, basically,” she said.

PLEASANT MUSIC FOR YOUR CAFE, BAR, RESTAURANT, SWEET SHOP, HOME

SUITABLE MUSIC FOR YOGA LOVERS

Continue Reading

SCIENCE

Turkish quakes may be ‘rehearsal’ for big one in Istanbul – scientists

Published

on

A local newspaper cites experts warning of a potential catastrophe if an earthquake hits the country’s biggest city

Istanbul should prepare itself for a powerful quake, scientists and public figures have warned. This month’s disaster in southern Turkey, which claimed tens of thousands of lives, is a “rehearsal” for what could come next, they argued in the newspaper Hurriyet on Friday.

When the next Istanbul earthquake happens, the damage “will swallow everyone,” unless people drop their differences and work on improving the seismic resilience of the city, Turkish author Nedim Sener wrote.

He cited a risk assessment by Bogazici University’s quake research lab, which counted how many buildings would be impacted by an earthquake of 7.5+ magnitude in Türkiye’s most populous and economically vital hub. With almost 13,500 structures expected to be heavily damaged, and hundreds of thousands of others affected to a smaller degree, the loss of life would be greater than what the country has just experienced, Sener predicted.

Some Turkish officials, including Istanbul Mayor Ekrem Imamoglu, have voiced similar concerns. The head of the city administration said 90,000 structures were at risk of total collapse in case of a major earthquake, citing a fresh survey by his municipality.

Cost of Türkiye quake damage estimated

Speaking in a TV interview this week, Imamoglu criticized the central government for issuing an amnesty to some 317,000 buildings which failed to meet earthquake resilience codes. It meant that the owners were allowed to pay a fine rather than demolish their properties.

Istanbul is located near a tectonic fault line that passes under the Marmara Sea. The 1999 quake in Izmit, which killed over 17,000 people, struck some 80 kilometers east of the city center, and half that distance from its easternmost suburbs.

Turkish Seismologist Naci Gorur, from Istanbul Technical University, warned that the risk of a major quake hitting Istanbul in the near future was growing. The probability of a tremor measuring over 7 magnitude occurring near the city within 30 years has increased from 62% in the aftermath of the 1999 disaster to 80% now, he said during a TV appearance. The scientists cited calculations by Tom Parsons, a fellow researcher at the US Geological Survey.

The twin quakes on February 6 caused massive devastation in Türkiye and northern Syria. Their combined death toll is estimated at around 44,000, including over 38,000 on the Turkish side.

SUITABLE MUSIC FOR YOGA LOVERS

PLEASANT MUSIC FOR YOUR CAFE, BAR, RESTAURANT, SWEET SHOP, HOME

Continue Reading

Trending